DENCAS12M

DENCAS12M has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 29, 2026: “Compact tool activates several genes at once in mice”.

Intervention

1 paper studies it1 findingUpdated

1 new paper in 30 daysSee all 1

  • 1 lab in 1 country
  • Animals1

What did studies of DENCAS12M find?

1

Studies of DENCAS12M measured 1 outcome; the most studied are Duchenne muscular dystrophy (1 study).

Duchenne muscular dystrophy

downin mice1

1 study
  1. DENCAS12M decreases Duchenne muscular dystrophy in mouse models.

    “We demonstrate phenotypic rescue in mouse models of Duchenne muscular dystrophy and Scn1a haploinsufficiency.”

    Animalsin mouse models

    Compact tool activates several genes at once in mice

    Nature biotechnology

More on Duchenne muscular dystrophy

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
Nature Biotechnology

Compact tool activates several genes at once in mice

A single virus-based delivery vehicle carried up to eight guide RNAs to activate six different genes in mice.A single virus-based delivery vehicle carried up to eight guide RNAs to activate six different genes in mice.

Mouse studyInterventions